Iterum Therapeutics Provides Update on FDA Advisory Committee Discussion of Oral Sulopenem for the Treatment of uUTI in Adult Women Sep 10, 2024
Iterum Therapeutics to Present at the 26th Annual H.C. Wainwright Global Investment Conference Sep 6, 2024
Iterum Therapeutics Announces FDA Advisory Committee Meeting to discuss NDA for Oral Sulopenem for the treatment of Uncomplicated Urinary Tract Infections Jun 21, 2024
